Literature DB >> 10931796

Alcohol septal ablation in hypertrophic obstructive cardiomyopathy: the need for a registry.

W H Spencer, R Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10931796     DOI： 10.1161/01.cir.102.6.600

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

1.  One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.

Authors:  L Faber; D Welge; D Fassbender; H K Schmidt; D Horstkotte; H Seggewiss
Journal:  Clin Res Cardiol       Date:  2007-09-25       Impact factor: 5.460

2.  Percutaneous transluminal septal myocardial ablation in hypertrophic cardiomyopathy.

Authors:  C van der Lee; D P Foley; W B Vletter; F J Ten Cate; M J M Kofflard
Journal:  Neth Heart J       Date:  2001-05       Impact factor: 2.380

3.  Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society.

Authors:  L Faber; H Seggewiss; F H Gietzen; H Kuhn; P Boekstegers; L Neuhaus; L Seipel; D Horstkotte
Journal:  Z Kardiol       Date:  2005-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.